|
|
|
|
|
|
|
|
|
|
the newly released share package of DiaMonTech AG is almost fully subscribed. If you haven’t invested yet but want to be part of this exceptional MedTech growth journey, now is the time to act.
In the initial phase of the funding round, not only our Companists but also renowned investors like technology giant Samsung came on board. Due to overwhelming demand, the round was briefly reopened and now, this new allocation is also nearly fully subscribed.
You can still invest from as little as €250 - while shares last.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Companisto GmbH |
|
Köpenicker Str. 154, 10997 Berlin
Managing Director: Tamo Zwinge, LL. M. and David Rhotert
Amtsgericht: Berlin Charlottenburg HRB 132811 B
VAT-ID: DE 276 014 929
Phone: +49 30 330 837 49
Email: service@companisto.com |
|
|
|
|
|
|
|
|
| You receive this newsletter because you have subscribed to it. You can unsubscribe at any time via the unsubscribe link. |
|
| The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity. |
|
|
|
|
|
|
